| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Myrrh | Acute Liver Injury | 1 | PM | 25864920 | 📋 | Hepatoprotective effect of Commiphora myrrha against d-GalN/LPS-induced hepatic injury in a rat model through attenuation of pro inflammatory cytokines and related genes |
| Myrrh | Gastric Cancer | 1 | PM | 32364228 | 📋 | Myrrh induces the apoptosis and inhibits the proliferation and migration of gastric cancer cells through down-regulating cyclooxygenase-2 expression |
| Myrrh | Gastric Ulcer | 1 | PM | 34829707 | 📋 | Commiphora myrrh Supplementation Protects and Cures Ethanol-Induced Oxidative Alterations of Gastric Ulceration in Rats |
| Myrrh | Gastrointestinal Disorders | 1 | PM | 25590370 | 📋 | Antispasmodic effects of myrrh due to calcium antagonistic effects in inflamed rat small intestinal preparations |
| Myrrh | Hepatic Fibrosis | 1 | PM | 35983967 | 📋 | Myrrhone inhibits the progression of hepatic fibrosis by regulating the abnormal activation of hepatic stellate cells |
| Myrrh | Inflammatory Bowel Disease | 1 | PM | 38044939 | 📋 | Myrrh protects against IL-13-induced epithelial barrier breakdown in HT-29/B6 cells |
| Myrrh | Intestinal Permeability | 2 | PM | 38044939 | 📋 | Myrrh protects against IL-13-induced epithelial barrier breakdown in HT-29/B6 cells |
| Myrrh | Intestinal Permeability | 1 | PM | 27981377 | 📋 | Myrrh exerts barrier-stabilising and -protective effects in HT-29/B6 and Caco-2 intestinal epithelial cells |
| Myrrh | Intestinal Spasm | 1 | PM | 25590370 | 📋 | Antispasmodic effects of myrrh due to calcium antagonistic effects in inflamed rat small intestinal preparations |
| Myrrh | Irritable Bowel Syndrome | 1 | PM | 36559534 | 📋 | Myrrh and Chamomile Flower Extract Inhibit Mediator Release from IgE-stimulated Mast-Cell-Like RBL-2H3 Cells |
| Myrrh | Liver Cancer | 6 | PM | 37719039 | 📋 | Water extract of frankincense and myrrh inhibits liver cancer progression and epithelial‑mesenchymal transition through Wnt/β‑catenin signaling |
| Myrrh | Liver Cancer | 5 | PM | 35317323 | 📋 | Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways |
| Myrrh | Liver Cancer | 2 | PM | 34319038 | 📋 | The Therapeutic Effect of Myrrh (Commiphora molmol) and Doxorubicin on Diethylnitrosamine Induced Hepatocarcinogenesis in Male Albino Rats |
| Myrrh | Liver Cancer | 1 | PM | 34135662 | 📋 | Commiphora myrrha (Nees) Engl. resin extracts induce phase-I cytochrome P450 2C8, 2C9, 2C19, and 3A4 isoenzyme expressions in human hepatocellular carcinoma (HepG2) cells |
| Myrrh | Liver Cancer | 4 | PM | 29784005 | 📋 | CD8 + T cells mediate the antitumor activity of frankincense and myrrh in hepatocellular carcinoma |
| Myrrh | Liver Cancer | 3 | PM | 28414157 | 📋 | Commiphora molmol resin attenuates diethylnitrosamine/phenobarbital-induced hepatocarcinogenesis by modulating oxidative stress, inflammation, angiogenesis and Nrf2/ARE/HO-1 signaling |
| Myrrh | Ulcerative Colitis | 1 | PM | 31688306 | 📋 | Distinct patterns of short-chain fatty acids during flare in patients with ulcerative colitis under treatment with mesalamine or a herbal combination of myrrh, chamomile flowers, and coffee charcoal: secondary analysis of a randomized controlled trial |
| Myrrh | Ulcerative Colitis | 2 | PM | 27446268 | 📋 | Myrrh attenuates oxidative and inflammatory processes in acetic acid-induced ulcerative colitis |
